PartnershipUpdated on 11 September 2025
Boost adherence and outcomes in women’s chronic health
About
We partner with pharma companies and healthcare providers to enhance women’s health outcomes. By integrating Mential’s AI-driven mental health programs into existing therapeutic pathways, we improve treatment adherence, increase real-world effectiveness, and maximize the impact of pharmaceutical and clinical interventions.
Our technology leverages artificial intelligence to optimize treatments, improve adherence, and reduce costs associated with traditional psychological support. This allows women to access the help they need from the comfort of their homes, without the need for travel.
-
Personalized Treatments: We tailor each psychological support program based on the specific needs of the patient and the disease they are facing.
-
Proven Effectiveness: Our treatments have been shown to be more effective than traditional methods, significantly improving medical and emotional outcomes.
-
Accessibility and Convenience: By offering services online, we eliminate geographic and time barriers, enabling more women to access the help they need.
-
Cost Reduction: By optimizing treatments and reducing the need for in-person visits, we help lower the costs associated with psychological support and improve treatment adherence, benefiting hospitals and pharmaceutical companies.
Organisation
Similar opportunities
Service
AI-powered mental health support tailored for women
Maria Natividad Chichón García
CEO-Cofounder en Mential at Mential
Madrid, Spain
Partnership
Digital twin technology for precision mental health
- Others
Maria Natividad Chichón García
CEO-Cofounder en Mential at Mential
Madrid, Spain
Service
HEWEGO: Empowering Patients and Supporting Clinical Trials through Personalized Digital Programs
- Digital health
- Health innovation
- Pharmaceutical industry
Gonzalo Cámara
CEO at HEWEGO
Madrid, Spain